Molecular mechanism of a cross-talk between estrogen and growth-factor signaling pathways

Oncology

Volumn 55, Issue SUPPL. 1, 1998, Pages 5-10

  Kato, Shigeaki ^a   Kitamoto, Takuya ^a   Masuhiro, Yoshikazu ^a   Yanagisawa, Junn ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Co activator; Estrogen receptor; Mitogen activated protein kinase; Transactivation domain; Transcription

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; TRANSACTIVATOR PROTEIN;

CANCER; CONFERENCE PAPER; HORMONE RECEPTOR INTERACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSACTIVATION;

BREAST NEOPLASMS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; ESTROGENS; FEMALE; GENITAL NEOPLASMS, FEMALE; GROWTH SUBSTANCES; HUMANS; PHOSPHORYLATION; RECEPTOR CROSS-TALK; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 0032436976     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055253     Document Type: Conference Paper

References (32)

1. Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan TR Jr, Lubahn DB, O'Donnell TF Jr, Korach KS, Mendelsohn ME: Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat Med 1997;3:545-548.
2. Brunner N, Boulay V, Fojo A, Freter CE, Lippman ME, Clarke R: Accquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications. Cancer Res 1993;53:283-290.
3. Beato M, Herrlich P, Schutz G: Steroid hormone receptors: Many actors in search of a plot. Cell 1995;83:851-857.
4. Green S, Chambon P: Nuclear receptors enhance our understanding of transcription regulation. Trends Genet 1988;4:309-314.
5. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P: The nuclear receptor superfamily: The second decade. Cell 1995;83:835-839.
6. Aronica SM, Katzenellenbogen BS: Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I. Mol Endocrinol 1993;7:743-752.
7. Ignar-Trowbridge DM, Pimentel M, Parker MG, McLachlan JA, Korach KS: Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology 1996;137:1735-1744.
8. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P: Activation of the estrogen receptor through phosphorylation by mitogen-activated protein-kinase. Science 1995;270:1491-1494.
9. Evans RM: The steroid and thyroid hormone receptor superfamily. Science 1988;240:889-895.
10. Gronemeyer H: Transcription activation by estrogen and progesterone receptors. Annu Rev Genet 1991;25:89-123.
11. Parker MG: Steroid and related receptors. Curr Opin Cell Biol 1993;5:499-504.
12. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA: Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996;93:5925-5930.
13. Lees JA, Fawell SE, Parker MG: Identification of two transactivation domains in the mouse oestrogen receptor. Nucleic Acids Res 1989;17: 5477-5488.
14. Tora L, White R, Brou C, Tasset D, Webster N, Scheer E, Chambon P: The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 1989;59: 477-487.
15. Ali S, Metzger D, Bornert JM, Chambon P: Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. EMBO J 1993; 12:1153-1160.
16. Arnold SF, Obourn JD, Yudt MR, Carter TH, Notides AC: In vivo and in vitro phosphorylation of the human estrogen receptor. J Steroid Biochem Mol Biol 1995;52:159-171.
17. Denton RR, Koszewski NJ, Notides AC: Estrogen receptor phosphorylation. Hormonal dependence and consequence on specific DNA binding. J Biol Chem 1992;267:7263-7268.
18. Le Goff P, Montano MM, Schodin DJ, Katzenellenbogen BS: Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. J Biol Chem 1994;269:4458-4466.
19. Gotoh Y, Nishida E: The MAP kinase cascade: Its role in Xenopus oocytes, eggs and embryos. Prog Cell Cycle Res 1995;1:287-297.
20. Hill CS, Treisman R: Transcriptional regulation by extracellular signals: Mechanisms and specificity. Cell 1995;80:199-211.
21. Pelech SL, Sanghera JS: MAP kinases: Charting the regulatory pathways. Science 1992;257:1355-1356.
22. Gullick WJ: Growth factors and oncogenes in breast cancer. Prog Growth Factor Res 1990;2: 1-13.
23. Murphy LC, Dotzlaw H, Wong MS, Miller T, Mrockowski B, Gong Y, Murphy LJ: Epidermal growth factor: Receptor and ligand expression in human breast cancer. Semin Cancer Biol 1990;1:305-315.
24. Bunone G, Briand PA, Miksicek RJ, Picard D: Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 1996;15:2174-2183.
25. Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F, Giguere V: Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta. Mol Endocrinol 1997;11:353-365.
26. Endoh H, Sasaki H, Maruyama K, Takeyama K, Waga I, Shimizu T, Kato S, Kawashima H: Rapid activation of MAP kinase by estrogen in the bone cell line. Biochem Biophys Res Commun 1997;235:99-102.
27. Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L: Nuclear receptor coactivators and corepressors. Mol Endocrinol 1996; 10:1167-1177.
28. Heery DM, Kalkhoven E, Hoare S, Parker MG: A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 1997;387:733-736.
29. Voegel JJ, Heine MJ, Tini M, Vivat V, Chambon P, Gronemeyer H: The coactivator TIF2 contains three nuclear receptor binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. EMBO J 1998;17:507-519.
30. Torchia J, Rose DW, Inostroza J, Kamei Y, Westin S, Glass CK, Rosenfeld MG: The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 1997;387:677-684.
31. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y, Evans RM: Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 1997;90:569-580.
32. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, Rosenfeld MG: A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 1996; 85:403-414.